Hpgc Renmintongtai Pharmaceutical Corporation Class ASSE: 600829

Announcement on Reply to Inquiry Letter for Information Disclosure Supervision of 2024 Annual Report

· Issued by Hpgc Renmintongtai Pharmaceutical Corporation Class A via Shanghai Stock Exchange
Announcement on Reply to Inquiry Letter for Information Disclosure Supervision of 2024 Annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment